Comprometidos con Ayudarle a Conseguir Sus Medicamentos

Saber qué esperar puede suponer una gran diferencia. Podemos ayudarle en todos los pasos necesarios para obtener VENCLEXTA.

Preguntas Frecuentes

Acerca de VENCLEXTA Access Solutions

VENCLEXTA Access Solutions es un recurso para personas que toman VENCLEXTA. Le brindamos acceso al medicamento que necesita.

Me Preocupa Tener Que Pagar VENCLEXTA

Puede haber opciones para ayudarle a conseguir el VENCLEXTA que le ha prescrito el médico. VENCLEXTA Access Solutions puede derivarle a diversas opciones de asistencia a pacientes.

Hemos cambiado el nombre de GATCF a Genentech Patient Foundation. Hemos hecho este cambio como muestra del compromiso que tenemos por ayudar a los pacientes y para que sea más fácil de recordar.

Cómo Conseguir Mi Medicamento

No puede recoger VENCLEXTA en una farmacia local. Deberá recogerlo en una farmacia especializada.

Una farmacia especializada es diferente a una farmacia normal de pedidos por correo. Sirve fármacos como VENCLEXTA.

Cuando comprobemos su cobertura, también le derivaremos a una farmacia especializada que cubra su plan de seguro médico.

Podría suceder que no le den VENCLEXTA inmediatamente. En primer lugar, la consulta de su médico o la farmacia especializada deberán verificar que su plan de seguro médico cubra esta medicamento. Esto es lo que se llama “investigación de prestaciones” (benefits investigation). Quizá deban también enviar más información antes de que su plan cubra el medicamento. Esto es lo que se llama “autorización previa” (prior authorization).

Cómo Inscribirse en VENCLEXTA Access Solutions

  1. Debe rellenar el formulario llamado PAN.
  2. Su médico debe rellenar el formulario llamado SMN. Usted no tiene que rellenar nada en este formulario.
  3. Su médico envía los dos formularios a VENCLEXTA Access Solutions.

Hay dos formas de rellenar el formulario PAN:

  • Puede rellenar el formulario en línea por internet 
  • Puede descargarlo e imprimirlo para cumplimentarlo en papel

El formulario PAN nos permite comentar su información sobre salud con su médico y su plan de seguro médico. No podemos trabajar con usted sin tener el PAN firmado.

Usted no necesita hacer nada más, pero su médico sí. Debe enviar el formulario llamado Declaración de Necesidad Médica (SMN por sus siglas en inglés). Este formulario nos indica que su médico quiere tratarle con VENCLEXTA. Asegúrese de que el médico nos envía el SMN para que le podamos ayudar.

Usted no tiene que rellenar nada en el formulario SMN.

Mi Plan Médico ha Rechazado la Cobertura de VENCLEXTA

Si su plan de seguro médico no cubre VENCLEXTA, usted y la consulta de su médico pueden realizar una apelación. Consulte a su médico para saber si necesita presentar una petición.

Disponemos de recursos para ayudarle a usted y a su médico a realizar una apelación.

Disponemos de recursos para ayudarle a usted y a su médico a realizar una apelación. Usted o la consulta de su médico debe realizar una apelación directamente con su plan de seguro médico.

Esto depende de su plan de seguro médico. Debe preguntar directamente a su plan cuál es su proceso. En ocasiones el proceso de apelación es rápido. No obstante, una apelación puede tardar varios meses si apela varias veces.

Mi Seguro Médico Puede Cambiar

Si su seguro cambia mientras está tomando VENCLEXTA, llámenos. Podemos ayudarle a comprender su nueva cobertura.

Genentech Patient Foundation proporciona VENCLEXTA gratis a las personas que no tienen cobertura de seguro o que tienen problemas financieros, y a personas con determinado nivel de ingresos.

Es responsabilidad suya y de su médico cumplimentar y enviar toda la documentación necesaria a su plan de seguro médico. VENCLEXTA Access Solutions no puede garantizar que su plan cubra los tratamientos.

PAN=siglas en inglés de Autorización del Paciente y Aviso de Solicitud Para Transmitir Información Médica a Genentech Access Solutions y a Genentech® Access to Care Foundation.

SMN=siglas en inglés de Declaración de Necesidad Médica.

Important Safety Information & Indication

What it Treats

What is VENCLEXTA® (venetoclax tablets)?

VENCLEXTA is a prescription medicine used:

  • to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, who have received at least 1 prior treatment.
  • in combination with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly-diagnosed acute myeloid leukemia (AML) who:
    • are 75 years of age or older, or
    • have other medical conditions that prevent the use of standard chemotherapy.

It is not known if VENCLEXTA is safe and effective in children.

Important Safety Information

What is the most important information I should know about VENCLEXTA?

VENCLEXTA can cause serious side effects, including:

Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure, the need for dialysis treatment, and may lead to death. Your healthcare provider will do tests to check your risk of getting TLS before you start taking VENCLEXTA. You will receive other medicines before starting and during treatment with VENCLEXTA to help reduce your risk of TLS. You may also need to receive intravenous (IV) fluids into your vein. Your healthcare provider will do blood tests to check for TLS when you first start treatment and during treatment with VENCLEXTA. It is important to keep your appointments for blood tests. Tell your healthcare provider right away if you have any symptoms of TLS during treatment with VENCLEXTA, including fever, chills, nausea, vomiting, confusion, shortness of breath, seizures, irregular heartbeat, dark or cloudy urine, unusual tiredness, or muscle or joint pain.

Drink plenty of water during treatment with VENCLEXTA to help reduce your risk of getting TLS. Drink 6 to 8 glasses (about 56 ounces total) of water each day, starting 2 days before your first dose, on the day of your first dose of VENCLEXTA, and each time your dose is increased.

Your healthcare provider may delay, decrease your dose, or stop treatment with VENCLEXTA if you have side effects.

Who should not take VENCLEXTA?

Certain medicines must not be taken when you first start taking VENCLEXTA and while your dose is being slowly increased because of the risk of increased tumor lysis syndrome (TLS).

  • Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VENCLEXTA and other medicines may affect each other, causing serious side effects.
  • Do not start new medicines during treatment with VENCLEXTA without first talking with your healthcare provider.

Before taking VENCLEXTA, tell your healthcare provider about all of your medical conditions, including if you:

  • have kidney problems.
  • have problems with your body salts or electrolytes, such as potassium, phosphorus, or calcium.
  • have a history of high uric acid levels in your blood or gout.
  • are scheduled to receive a vaccine. You should not receive a “live vaccine” before, during, or after treatment with VENCLEXTA, until your healthcare provider tells you it is okay. If you are not sure about the type of immunization or vaccine, ask your healthcare provider. These vaccines may not be safe or may not work as well during treatment with VENCLEXTA.
  • are pregnant or plan to become pregnant. VENCLEXTA may harm your unborn baby. If you are able to become pregnant, your healthcare provider should do a pregnancy test before you start treatment with VENCLEXTA, and you should use effective birth control during treatment and for at least 30 days after the last dose of VENCLEXTA. If you become pregnant or think you are pregnant, tell your healthcare provider right away.
  • are breastfeeding or plan to breastfeed. It is not known if VENCLEXTA passes into your breast milk. Do not breastfeed during treatment with VENCLEXTA. 

What should I avoid while taking VENCLEXTA?

You should not drink grapefruit juice, eat grapefruit, Seville oranges (often used in marmalades), or starfruit while you are taking VENCLEXTA. These products may increase the amount of VENCLEXTA in your blood.

What are the possible side effects of VENCLEXTA?

VENCLEXTA can cause serious side effects, including:

  • Low white blood cell counts (neutropenia). Low white blood cell counts are common with VENCLEXTA, but can also be severe. Your healthcare provider will do blood tests to check your blood counts during treatment with VENCLEXTA. Tell your healthcare provider right away if you have a fever or any signs of an infection during treatment with VENCLEXTA.

The most common side effects of VENCLEXTA when used in combination with rituximab in people with CLL include low white blood cell counts, diarrhea, upper respiratory tract infection, cough, tiredness, and nausea.

The most common side effects of VENCLEXTA when used alone in people with CLL/SLL include low white blood cell counts; diarrhea; nausea; upper respiratory tract infection; low red blood cell counts; tiredness; low platelet counts; muscle and joint pain; swelling of your arms, legs, hands, and feet; and cough.

The most common side effects of VENCLEXTA in combination with azacitidine or decitabine or low-dose cytarabine in people with AML include low white blood cell counts; nausea; diarrhea; low platelet counts; constipation; fever with low white blood cell counts; low red blood cell counts; infection in blood; rash; dizziness; low blood pressure; fever; swelling of your arms, legs, hands, and feet; vomiting; tiredness; shortness of breath; bleeding; infection in lung; stomach (abdominal) pain; pain in muscles or back; cough; and sore throat.

VENCLEXTA may cause fertility problems in males. This may affect your ability to father a child. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of VENCLEXTA. For more information, ask your healthcare provider or pharmacist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you cannot afford your medication, contact www.pparx.org for assistance.

For additional safety information, please see the full Prescribing information and Medication Guide.